We are live on
!
Find out more
Clearstead Advisors Portfolio holdings
AUM
$10.6B
Turnover
42.91%
1-Year Est. Return
24.87%
This Fund
S&P 500
This Quarter
Est. Return
+14.75%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.44%
5 Year Est. Return
+80.35%
10 Year Est. Return
–
AUM
$10.6B
AUM Growth
-$353M
(-3.2%)
Cap. Flow
-$277M
Cap. Flow
% of AUM
-2.62%
Top 10 Holdings %
Top 10 Hldgs %
28.93%
Holding
3,754
New
1,518
Increased
1,198
Reduced
637
Closed
93
Avg Time Held Equity + Options
2
years
Top 10 Avg Time Held Equity + Options
3
years
Top 20 Avg Time Held Equity + Options
3
years
Avg Time Held Equity only
2
years
Top 10 Avg Time Held Equity only
3
years
Top 20 Avg Time Held Equity only
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$967M |
| 2 |
NVIDIA
NVDA
|
+$132M |
| 3 |
Baillie Gifford Long Term Global Growth ETF
BGGG
|
+$122M |
| 4 |
Sonoco
SON
|
+$35.5M |
| 5 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$23.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PACCAR
PCAR
|
+$287M |
| 2 |
Microsoft
MSFT
|
+$137M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$124M |
| 4 |
Dimensional International High Profitability ETF
DIHP
|
+$84.2M |
| 5 |
Starbucks
SBUX
|
+$73.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.29% |
| 2 | Technology | 11.98% |
| 3 | Industrials | 7.46% |
| 4 | Financials | 5.38% |
| 5 | Consumer Discretionary | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3001
Westrock Coffee
WEST
$821M
| $391 | ﹤0.01% |
+48
| New | +$345 |
2026 Q2
0 quarters
|
|
3002
AMN Healthcare
AMN
$1.56B
| $390 | ﹤0.01% |
+12
| New | +$310 |
2026 Q2
0 quarters
|
|
3003
LSB Industries
LXU
$781M
| $390 | ﹤0.01% |
+36
| New | +$482 |
2026 Q2
0 quarters
|
|
3004
QCR Holdings
QCRH
$1.62B
| $390 | ﹤0.01% |
+4
| New | +$367 |
2026 Q2
0 quarters
|
|
3005
Flywire
FLYW
$2.29B
| $387 | ﹤0.01% |
+22
| New | +$325 |
2026 Q2
0 quarters
|
|
3006
QuidelOrtho
QDEL
$928M
| $386 | ﹤0.01% |
+22
| New | +$291 |
2026 Q2
0 quarters
|
|
3007
Sight Sciences
SGHT
$458M
| $386 | ﹤0.01% |
+71
| New | +$327 |
2026 Q2
0 quarters
|
|
3008
LeMaitre Vascular
LMAT
$1.87B
| $384 | ﹤0.01% |
+4
| New | +$410 |
2026 Q2
0 quarters
|
|
3009
Perella Weinberg Partners
PWP
$1.03B
| $384 | ﹤0.01% |
+24
| New | +$439 |
2026 Q2
0 quarters
|
|
3010
ACM Research
ACMR
$3.79B
| $381 | ﹤0.01% |
+3
| New | +$212 |
2026 Q2
0 quarters
|
|
3011
KinderCare Learning Companies
KLC
$211M
| $379 | ﹤0.01% |
+89
| New | +$329 |
2026 Q2
0 quarters
|
|
3012
Tarsus Pharmaceuticals
TARS
$3.24B
| $378 | ﹤0.01% |
+6
| New | +$383 |
2026 Q2
0 quarters
|
|
3013
Edgewell Personal Care
EPC
$1.29B
| $377 | ﹤0.01% |
+14
| New | +$299 |
2026 Q2
0 quarters
|
|
3014
Knowles
KN
$2.87B
| $374 | ﹤0.01% |
+9
| New | +$312 |
2026 Q2
0 quarters
|
|
3015
Supernus Pharmaceuticals
SUPN
$2.19B
| $373 | ﹤0.01% |
+8
| New | +$384 |
2026 Q2
0 quarters
|
|
3016
Brookdale Senior Living
BKD
$2.38B
| $371 | ﹤0.01% |
+23
| New | +$313 |
2026 Q2
0 quarters
|
|
3017
Ducommun
DCO
$2.55B
| $371 | ﹤0.01% |
+2
| New | +$297 |
2026 Q2
0 quarters
|
|
3018
NextDecade
NEXT
$1.61B
| $371 | ﹤0.01% |
+49
| New | +$388 |
2026 Q2
0 quarters
|
|
3019
Arcturus Therapeutics
ARCT
$299M
| $370 | ﹤0.01% |
+55
| New | +$434 |
2026 Q2
0 quarters
|
|
3020
Surgery Partners
SGRY
$1.92B
| $370 | ﹤0.01% |
+22
| New | +$309 |
2026 Q2
0 quarters
|
|
3021
Sensient Technologies
SXT
$5.68B
| $370 | ﹤0.01% |
+3
| New | +$334 |
2026 Q2
0 quarters
|
|
3022
RCI Hospitality Holdings
RICK
$198M
| $369 | ﹤0.01% |
13
+2
| +18% | +$51 |
2024 Q1
9 quarters
|
|
3023
Coty
COTY
$2.81B
| $366 | ﹤0.01% |
169
+59
| +54% | +$127 |
2024 Q1
9 quarters
|
|
3024
CoreCivic
CXW
$3B
| $365 | ﹤0.01% |
+12
| New | +$272 |
2026 Q2
0 quarters
|
|
3025
Crescent Energy
CRGY
$5.57B
| $364 | ﹤0.01% |
+37
| New | +$452 |
2026 Q2
0 quarters
|
|
Similar funds
Clearstead Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Clearstead Advisors held 3,754 positions worth $10.6B, down 3.2% from $10.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Clearstead Advisors's Q2 2026 filing shows 1,518 new, 1,198 increased, 637 reduced and 93 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M. The largest sale was PACCAR, an estimated $287M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.
- Clearstead Advisors's largest Q2 2026 buy was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M.
- Clearstead Advisors added most to Sonoco in Q2 2026, an estimated $35.5M increase.
- Clearstead Advisors's biggest Q2 2026 reduction was PACCAR, cutting an estimated $287M.
- Clearstead Advisors fully exited iShares Currency Hedged MSCI Japan ETF in Q2 2026, selling an estimated $9.02M.
- Clearstead Advisors's ten largest holdings make up 29% of its $10.6B portfolio in Q2 2026.
- Clearstead Advisors opened 1,518 new positions and closed 93 in Q2 2026.
- Clearstead Advisors's portfolio value fell 3.2% quarter-over-quarter to $10.6B.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.